XML 74 R68.htm IDEA: XBRL DOCUMENT v3.25.3
Earnings (loss) per share - Schedule of Earnings per Share (Detail) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]        
Net income (loss) attributable to Teva's ordinary shareholders $ 433 $ (437) $ 930 $ (1,422)
Weighted average shares outstanding 1,147 1,133 1,144 1,130
Basic earnings (loss) attributable to Teva's ordinary shareholders $ 0.38 $ (0.39) $ 0.81 $ (1.26)
Diluted effect of stock options, RSUs and PSUs 17   16  
Total dilutive shares outstanding 1,164 1,133 1,160 1,130
Diluted earnings (loss) attributable to Teva's ordinary shareholders $ 0.37 $ (0.39) $ 0.8 $ (1.26)